United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
09 avr. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, April 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a global healthcare awareness initiative with...
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
01 avr. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire...
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
26 mars 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND...
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
12 mars 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement...
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
29 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board...
CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors
15 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has appointed William (Bill) Yuan to...
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
09 janv. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
26 nov. 2018 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has secured a new registration with the...
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
14 nov. 2018 07h25 HE
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s...
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
01 nov. 2018 07h25 HE
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...